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Expert advice is that those taking systemic corticosteroids
should take the tablets in the morning to reduce the risk of
suppression of the hypothalamo-pituitary–adrenal (HPA)
axis (1,2). Systemic steroid administration in the evening is
more likely to cause clinically significant HPA suppression
(3). For some years printed advice to patients attending this
chest clinic under the care of one of the consultants has
advised the morning use of tablets, but we decided to survey
how patients attending this chest clinic and a rheumatology
clinic in the same hospital actually used their tablets.
Methods
For a 2 month period a poster and a supply of
questionnaires was placed prominently in the three waiting
rooms in the chest clinic. The poster invited patients who
had ever been given steroid tablets to complete one of the
questionnaires and hand it to the reception staff. Over the
same time period, our respiratory nurse specialists offered
the questionnaire to patients who had used steroid tablets,
and a nurse specialist in a rheumatology clinic similarly
asked appropriate patients to complete the questionnaire.
The aim was to obtain a response from 50 patients with
rheumatological conditions, and as many as possible
completed forms from chest clinic patients. The question-
naire was designed to capture information on diagnosis, the
number of steroid courses taken in the last 10 years and
how the patients took the tablets. A number of options
regarding different methods of taking oral steroids were
offered, and patients were asked to circle the option which
was most similar to their practice. They were also asked
about the advice they had received from doctors about oral
steroid administration, and whether they had received
written instructions.
Results
A total of 151 questionnaires were completed by patients
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and 90 (60%) by those attending the chest clinic. The two
biggest indications for tablet steroid therapy were rheuma-
toid arthritis [48 patients (32%)] and asthma [43 patients
(29%)], but the range of conditions included chronic
obstructive pulmonary disease, fibrosing alveolitis, sarcoi-
dosis, polymyalgia rheumatica, systemic lupus erythema-
tosis, malignancy, Bechets syndrome and Wegeners.
Fifty-two of the patients (34%) were on continuous
steroids; 25 for rheumatological conditions (48%). Fifty-
eight of the patients had had less than five courses of
steroids previously (38%), 15 (10%) had had between five
and 10 courses of steroids previously and 12 (8%) had had
more than 10 previous treatment courses with steroid
tablets.
Ninety-seven of the patients (64%) reported taking all of
their tablets in the morning, 16 (11%) reported taking
tablets in the morning, at lunchtime and at bedtime, 13
(9%) said they took their tablets in the morning and at
bedtime; nine (6%) took them in the morning, in the
afternoon and at teatime. Four patients (3%) took
the tablets in the middle of the afternoon and five of
the patients (3%) said that they took all of their tablets at
bedtime. Two patients did not answer this question and
four described some way of taking their medication other
than in the morning. No different patterns of use were
discernible between diseases and between those on regular
steroids and intermittent users.
One hundred and four patients (69%) reported that they
had received verbal instructions as to when to take the
tablets and these were equally distributed amongst rheu-
matology and chest clinic patients. Only 49 patients (33%)
said that they had received written instructions. The advice
most commonly reported being received was ‘all together at
breakfast’ or ‘in the morning’.
Discussion
With any prescription the prime consideration is to gain
maximum benefit with minimal side-effects. With systemic
steroid therapy the potential for adverse endocrinological
effects seems to be less if the steroids are taken in the early
morning. Morning use coincides with peak diurnal ACTH
levels and this results in significantly less adrenal suppres-
sion than when steroids are taken in divided doses or at
bedtime. Standard advice to take steroid tablets in the
morning is therefore based on a principle of dosing for# 2001 HARCOURT PUBLISHERS LTD
M. P. PARTDIGE ET AL. 91minimal side effects. However this may not be the time of
day when therapeutic ecacy is maximal and less is known
regarding the diurnal therapeutic ratio—i.e. the time of day
at which the ratio between desired and undesired effects is
optimal. With regards to asthma there is some suggestion
that once daily inhaled steroid therapy may be more
effective if taken in the evening (4), and there is some
evidence that oral steroids taken in the afternoon may be
best for those with severe night-time asthma (5). Until we
have a better understanding of diurnal variation in
therapeutic ratios, expert advice (1) and standard asthma
textbooks (6,7) advise dosing to minimize side-effects and
the morning use of steroid tablets.
In this study a third of patients did what might seem
logical in the absence of instructions and spread the tablet
taking throughout the day, or took them specifically at a
time other than the morning. Numerous studies have
highlighted how recall of the spoken word is poor, and yet
only one third of patients reported that they had received
written instructions. To avoid unnecessary side-effects,
patients being treated with steroid tablets for most
conditions should be given spoken and written instructions
to take all of their medication in the morning.
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